- Advertising
- Asia
- Bangladesh
- Biological Inventions
- BRAND VALUATION
- China
- Comparative Advertisement
- Copyright
- Copyright Infringement
- Copyright Litigation
- Counterfeiting
- Covid
- Data Protection
- Design
- Digital Marketing Rights
- DRM
- Electronics
- Geographical Indication
- India
- Indian Patents Act
- Indonesia
- Intellectual Property
- Interim Injunction
- IP Commercialization
- IP Licensing
- IP Litigation
- IP Practice in India
- IPAB
- IPAB Decisions
- Japan
- Legal Issues
- Licensing
- Malaysia
- Myanmar
- NCLT
- NEPAL
- Net Neutrality
- News & Updates
- Office
- Patent Commercialisation
- Patent Cooperation Treaty
- patent infringement
- Patent Licensing
- Patent Litigation
- Patent Opposition
- Patent Prosecution
- Patent Rule Amendment
- Patent Term Extension
- Patents
- pharma
- Philippines
- Punitive Damages
- Section 3(D)
- section 64
- Singapore
- South-east Asia
- Technology
- Technology Transfer
- Thailand
- Trademark
- Trademark Litigation
- UAE
- Uncategorized
- USPTO
- Vietnam
- WIPO
Corroboration of Rightful Ownership through Objection Provisions
Copyright Indian Copyright law is greatly inspired by and in congruence with the TRIPS agreement clauses and standards. The stipulations of the Berne Convention for Protection of Literary and Artistic Works, 1886 and the Universal Copyrights Convention, to which India is a party reflect strongly in the (Indian) Copyright Act, 1957, pursuant to the amendments … Continue reading Corroboration of Rightful Ownership through Objection Provisions
Read more »Role of Documentation in Protecting Traditional Knowledge
Domestic and International laws prohibit the patenting of traditional knowledge of any local community. However, traditional knowledge, such as unique plants and their use is being usurped by unscrupulous players by patenting them in different countries. The only way to stall such moves is by providing prior art evidence proving that the knowledge was … Continue reading Role of Documentation in Protecting Traditional Knowledge
Read more »Improving Regulatory Transparency for New Medical Therapies Act
A new act passed in the U.S. House of Representatives: What will it protect? Patent exclusivity, non-patent exclusivity, or both? Anything else also it deals with? The bill titled ‘A bill to amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to … Continue reading Improving Regulatory Transparency for New Medical Therapies Act
Read more »